Preparation of recombinant alpha-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin.

Preparation of recombinant alpha-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin.
复制标题

重组α-凝血酶的制备:重组人凝血酶前体2的高水平表达及其重组ecarin的激活。

DOI:
--
复制
发表时间:
2004
期刊:
Journal of Biochemistry (Tokyo)
影响因子:
--
通讯作者:
C. Nozaki
C. Nozaki
中科院分区:
--
文献类型:
--
作者:
H. Yonemura;T. Imamura;K. Soejima;Y. Nakahara;W. Morikawa;Y. Ushio;Yasuharu Kamachi;H. Nakatake;K. Sugawara;T. Nakagaki;C. Nozaki

文献摘要

参考文献

被引文献

相似文献

我们已经建立了大规模生产重组人α-凝血酶的生产系统。在该系统中,高产率的α-凝血酶是由重组ecarin激活的凝血酶原-2制备的。我们利用小鼠骨髓瘤细胞和携带鸡β-肌动蛋白启动子和突变型二氢叶酸还原酶基因的表达载体,生产了人凝血酶前2。为了进一步提高凝血酶原-2的表达,我们在50升悬浮培养中加入植物蛋白胨进行补料分批培养。经5次植物蛋白胨培养后,重组凝血酶原-2的表达水平达到200微克/毫升。随后,以类似方式表达的重组凝血酶原-2可被激活为α-凝血酶。最后,重组α-凝血酶经苯甲酰胺-琼脂糖凝胶亲和层析纯化为均一组分。在培养基中凝血酶原-2的产率约为70%。纯化的重组α-凝血酶的活性,包括对发色底物的水解、纤维蛋白肽A的释放和蛋白C的激活,与血浆来源的α-凝血酶没有区别。本系统适用于大规模生产重组α-凝血酶,可替代临床上可用的人或牛血浆来源的α-凝血酶。
We have established a large-scale manufacturing system to produce recombinant human alpha-thrombin. In this system, a high yield of alpha-thrombin is prepared from prethrombin-2 activated by recombinant ecarin. We produced human prethrombin-2 using mouse myeloma cells and an expression plasmid carrying the chicken beta-actin promoter and mutant dihydrofolate reductase gene for gene amplification. To increase prethrombin-2 expression further, we performed fed-batch cultivation with the addition of vegetable peptone in 50 liters of suspension culture. After five feedings of vegetable peptone, the expression level of the recombinant prethrombin-2 reached 200 micro g/ml. Subsequently, the recombinant prethrombin-2 could be activated to alpha-thrombin by recombinant ecarin expressed in a similar manner. Finally, recombinant alpha-thrombin was purified to homogeneity by affinity chromatography using a benzamidine-Sepharose gel. The yield from prethrombin-2 in culture medium was approximately 70%. The activity of the purified recombinant alpha-thrombin, including hydrolysis of a chromogenic substrate, release of fibrinopeptide A, and activation of protein C, was indistinguishable from that of plasma-derived alpha-thrombin. Our system is suitable for the large-scale production of recombinant alpha-thrombin, which can be used in place of clinically available alpha-thrombin derived from human or bovine plasma.
DOI: 10.1021/bi00107a001
发表时间: 1991-10-29
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
DAVIE, EW;FUJIKAWA, K;KISIEL, W
通讯作者: KISIEL, W
DOI: 10.1016/s0021-9258(18)34900-7
发表时间: 1982-03
期刊: The Journal of biological chemistry
影响因子: --
作者:
D. Tollefsen;D. Majerus;M. Blank
通讯作者: D. Tollefsen;D. Majerus;M. Blank
DOI: --
发表时间: 1988
期刊: Blood
影响因子: 20.3
作者:
Stricker,RB;Lane,PK;Leffert,JD;Rodgers,GM;Shuman,MA;Corash,L
通讯作者: Corash,L